Avita Medical - ADR Peer Comparison

$11.20

$0.26 (2.38%)

As on 04-Sep-2026 18:20EDT

Market cap

$346 Mln

Revenue (TTM)

$76 Mln

P/E Ratio

--

P/B Ratio

41

Div. Yield

0 %

Edit

	Avita Medical - ADR	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Market cap ($ Mln)	346	16,504	17,747	14,622	12,501
Revenue ($ Mln)	76	2,782	1,054	2,436	1,284
Net Profit ($ Mln)	-43.08	491.50	755.85	860.62	-325.10
Net Margin (%)	-56.96	17.67	71.69	35.33	-25.32
RoE (%)	--	110.09	--	42.98	-57.72
Price to Earnings	--	34.72	20.93	18.56	--
Price-To-Book	40.95	38.18	10.51	7.95	23.94

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Avita Medical - ADR	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Operating Revenue	75.63	2,782.29	1,054.37	2,435.92	1,283.94
Cost of Revenue	13.95	1,982.07	103.47	85.67	109.42
Gross Profit	58.82	760.62	588.53	2,236.43	902.26
Operating Expenses	96.90	216.81	841.45	1,378.74	1,497.13
Operating Profit (EBIT)	-35.22	583.40	109.45	971.51	-322.62
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-43.06	598.92	101.11	1,035.47	-325.10
Provision for Tax	0.02	107.42	-654.74	174.84	0.00
Profit after Tax (Net Income)	-43.08	491.50	755.85	860.62	-325.10
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Avita Medical - ADR	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Shareholder's Funds	-27.84	433.86	1,435.90	1,843.76	523.72
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	6.90	187.89	384.48	288.55	346.72
Current Liabilities	68.71	1,435.43	464.70	361.93	374.20
Total Liabilities	56.39	1,975.47	1,302.02	2,844.42	1,259.59

Assets ($ Mln)

	Avita Medical - ADR	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Non-Current Assets	19.38	1,006.90	895.24	1,243.41	45.47
Current Assets	28.39	1,050.29	1,389.84	1,250.82	1,199.18
Total Assets	56.39	1,975.47	1,302.02	2,844.42	1,259.59
Total Debt*	48.48	120.10	449.89	165.93	347.75
Net Current Assets	-40.32	-385.14	925.52	888.90	824.98

Cashflow ($ Mln)

	Avita Medical - ADR	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Cash From Operating Activities	-31.20	713.22	51.77	884.27	-189.55
Cash Flow from Investing Activities	12.45	-31.14	-8.15	350.44	32.32
Cash from Financing Activities	14.94	-860.39	34.89	-969.59	255.98
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Avita Medical - ADR	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
ROCE (%)	-121.65	53.56	-30.01	32.82	-31.49
ROE (%)	799.72	110.09	163.18	42.98	-57.72
ROA (%)	-36.32	15.64	31.68	29.32	-22.97
EBIT Margin (%)	-49.82	21.13	5.73	31.04	-18.97
Net Margin (%)	-56.96	17.67	71.69	35.33	-25.32
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Avita Medical - ADR	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Revenue Growth (%)	1.00	24.67	114.85	9.23	149.04
EBIT Growth (%)	18.85	18.70	136.39	-3.99	9.16
Net Profit Growth (%)	16.46	17.50	378.76	42.89	-15.32
EPS Growth (%)	26.02	26.84	353.27	50.42	-0.64
Book Value Growth (%)	-85.16	164.02	816.12	-0.70	-42.66

Valuation Ratios

	Avita Medical - ADR	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Price / Earnings	-2.16	36.06	-59.76	15.79	-45.32
Price / Book Value	-6.30	35.44	-80.42	5.72	21.68
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-3.22	28.08	-121.54	12.44	-47.02
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Avita Medical - ADR	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debt to Equity	0.00	0.00	0.27	0.00	0.65
Short term debt to equity ratio	-1.68	0.00	0.05	0.00	0.00
Current Ratio	0.41	0.73	2.99	3.46	3.20
Quick Ratio	0.34	0.73	2.32	3.38	2.94
Interest Coverage	-6.97	--	1.62	--	-9.32

Operating Efficiency Ratios

	Avita Medical - ADR	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debtors to sales (%)	13.05	15.88	21.25	13.74	14.98
Asset Turnover	0.64	0.89	0.44	0.83	0.91
Receivable days	53.73	50.42	85.52	43.48	35.88
Inventory Days	202.62	--	1,056.70	96.17	354.23
Payable days	217.73	6.26	331.01	147.97	300.79
Cash Conversion Cycle	38.63	--	811.21	-8.32	89.33

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly